Max Planck's Matthias Mann Discusses Technology Development and Clinical Proteomics

In the first part of a two-part interview, Mann discusses the state of technology in proteomics and what still needs to get done for proteomics to cross to the clinical side.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories